These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10070992)

  • 1. Renin profiling to predict response to antihypertensive therapy.
    Blaufox MD; Wassertheil-Smoller S
    JAMA; 1999 Mar; 281(9):793-4. PubMed ID: 10070992
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive treatment and plasma renin activity in essential hypertension.
    Chen WY; Hsieh BS; Yen TS; Cheng JT; Yang SM
    Taiwan Yi Xue Hui Za Zhi; 1976 Dec; 75(12):665-73. PubMed ID: 1071754
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 5. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension].
    Werning C; Stiel D; Hammann K; Schweikert HU; Fischer N; Siegenthaler W
    Fortschr Med; 1972 Jul; 90(20):785-7. PubMed ID: 5074231
    [No Abstract]   [Full Text] [Related]  

  • 6. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Timolol, hydrochlorothiazide, blood-pressure, and renin in essential hypertension.
    Fyhrquist F; Kurppa K; Kannas M
    Lancet; 1976 Sep; 2(7987):691-2. PubMed ID: 60553
    [No Abstract]   [Full Text] [Related]  

  • 9. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises.
    Sealey JE; Laragh JH
    Am J Hypertens; 2009 Jan; 22(1):112-21. PubMed ID: 18802434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of plasma renin estimation in the management of hypertension.
    Brown MJ
    Am J Hypertens; 2014 Aug; 27(8):1013-6. PubMed ID: 25103934
    [No Abstract]   [Full Text] [Related]  

  • 11. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pindolol as an antihypertensive agent].
    Pinggera WF; Fitscha P; Stummvoll HK; Wolf A; Dorda P
    Fortschr Med; 1977 Feb; 95(5):310-14. PubMed ID: 838451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
    Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
    Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Jun; 14(6 Pt 1):491-503. PubMed ID: 11411727
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
    McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
    Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients.
    Bühler FR; Bolli P; Kiowski W; Erne P; Hulthén UL; Block LH
    Am J Med; 1984 Aug; 77(2A):36-42. PubMed ID: 6148011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
    Trippodo NC; Robl JA; Asaad MM; Fox M; Panchal BC; Schaeffer TR
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension].
    Kobalava ZhD; Kotovskaia IuV; Kravtsova OA
    Kardiologiia; 2015; 55(2):21-6. PubMed ID: 26164984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
    Weintraub HS; Duprez DA; Cushman WC; Zappe DH; Purkayastha D; Samuel R; Izzo JL
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):145-55. PubMed ID: 22311004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. John H. Laragh, MD: clinician-scientist.
    Sealey JE
    Am J Hypertens; 2014 Aug; 27(8):1019-23. PubMed ID: 25103936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.